It is a pharma private limited company based in Llucknow, Uttar Pradesh, India, established in 1997.
1997 | Llucknow, Uttar Pradesh, India | ActiveDas Drugs Private Limited, a active private limited company, was established on 05 June 1997 in Llucknow, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51109UP1997PTC022083. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹3.89 Cr.
It upholds a compliant status. Employing 38 professional, Its leadership includes Manoj Rastogi (Director), Mehul Rastogi (Director), Anupama Rastogi (Director). Past directors included Krishna Kant, Chittaranjan Das, Tribhuwan Das. It holds ₹15.02 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C-1/14,Phase-Ii Transport Nagar, Llucknow, Uttar Pradesh, 226012.
U51109UP1997PTC022083
022083
05 June 1997
₹5.00 Cr
₹3.89 Cr
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Das Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manoj Rastogi | Director | 05 Jun 1997 | Current |
| Mehul Rastogi | Director | 20 Jan 2015 | Current |
| Anupama Rastogi | Director | 17 Jun 2009 | Current |
| Anurag Das | Director | 01 Apr 1998 | Current |
| Manjulata Rastogi | Director | 01 Apr 1998 | Current |
| Bharati Patwari Rastogi | Director | 15 Nov 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Jun 2009 | Past |
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Das Drugs Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.96% decrease. The company also saw a substantial fall in profitability, with a 14.55% decrease in profit. The company's net worth Soared by an impressive increase of 13.27%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Das Drugs had a promoter holding of 28.69% and a public holding of 71.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹150,213,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 May 2017 | Others | ₹7.50 M | Open |
| 29 Feb 2016 | Hdfc Bank Limited | ₹12.27 Cr | Open |
| 25 Feb 2016 | Hdfc Bank Limited | ₹2.00 Cr | Open |
Explore comprehensive loan charge details -
Das Drugs has a workforce of 38 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Das Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Das Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Das Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Das Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
The activity A charge with Hdfc Bank Limited of Rs. 12.27 Cr registered on 29 Feb 2016 with Charge ID 10627092 was modified on 25 Sep 2023. was completed.
Bharati Patwari Rastogi was appointed as a Director was appointed as a Director on 15 Nov 2022 & has been associated with this company since 3 years 15 days . was recorded as a recent event.
The activity A charge with Hdfc Bank Limited of Rs. 2.00 Cr registered on 25 Feb 2016 with Charge ID 10626797 was modified on 13 Oct 2020. was completed.
A charge with Others amounted to Rs. 0.75 Cr with Charge ID 100104198 was registered on 26 May 2017. was recorded as a recent event.
The CIN of Das Drugs Private Limited is U51109UP1997PTC022083.
Das Drugs Private Limited is headquartered at C-1/14,Phase-Ii Transport Nagar, Llucknow, Uttar Pradesh, 226012.
Das Drugs Private Limited was incorporated on 05 June 1997.
The current directors of Das Drugs Private Limited are
The primary industry of Das Drugs Private Limited is Trade.
Das Drugs Private Limited is unlisted.
The authorized capital of Das Drugs Private Limited is ₹5.00 Cr, and the paid-up capital is ₹3.89 Cr.
The compliance status of Das Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX